NovaGo Promobility Therapeutics
Human antibody therapeutics targeting cerebral stroke and spinal cord injury to stimulate nerve repair and regeneration. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$39—58m (Dealroom.co estimates Mar 2019.)
Schlieren Switzerland (HQ)
Authorizing premium user...